Physician profile
Jeffrey Berger
NPI 1235178955
$1,438.93
in general payments reported to CMS, 2019-2025
31 companies · $456 in 2025
The $456 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.93 · 2021: $21.48 · 2022: $206 · 2023: $418 · 2024: $314 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $167.23 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Polynovo North America LLC | $118.14 | 2025 | Novosorb Btm |
| Glaxosmithkline, LLC. | $106.00 | 2022-2024 | Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $95.38 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $82.61 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $81.37 | 2022-2023 | Xarelto |
| Lifenet Health | $80.68 | 2023-2025 | Theragenesis Wound Matrix |
| Medtronic, INC. | $61.27 | 2023 | Sonicision, Progrip |
| Lilly USA, LLC | $60.43 | 2025 | Emgality, Jardiance, Kisunla |
| Abbvie INC. | $53.70 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $51.65 | 2024-2025 | Farxiga, Airsupra |
| Actelion Pharmaceuticals US, INC. | $43.18 | 2024-2025 | Uptravi, Opsumit |
| Biohaven Pharmaceutical Holding Company LTD. | $42.47 | 2022 | |
| Esperion Therapeutics, INC. | $36.78 | 2024-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $33.39 | 2024 | Gardasil 9, Capvaxive, Gardasil |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $28.83 | 2022-2024 | Xyosted |
| Corcept Therapeutics | $27.58 | 2025 | Korlym |
| Abbott Laboratories | $24.75 | 2024 | Proclaim |
| Integra Lifesciences Corporation | $23.93 | 2020 | |
| Teleflex LLC | $22.80 | 2023 | Quikclot |
| Kyowa Kirin, INC. | $22.39 | 2023 | Crysvita |
| Bard Peripheral Vascular, INC. | $21.48 | 2021 | |
| Pfizer INC. | $20.74 | 2022 | |
| Sanara Medtech INC. | $20.62 | 2025 | Celleraterx |
| Innovation Technologies INC | $18.75 | 2025 | Irrisept |
| Avanos Medical | $17.82 | 2023 | On-Q* Pump and Accessories |
| Idorsia Pharmaceuticals US INC | $17.01 | 2022 | |
| Ethicon US, LLC | $16.08 | 2024 | Zip Pen, Smartablatetm System Rf Generator, Ultra Vac |
| Myriad Genetic Laboratories, INC. | $15.48 | 2022 | |
| Boston Scientific Corporation | $14.09 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.